FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$9,788,542
-0.2%
96,098
-1.1%
0.07%
+4.2%
Q2 2023$9,806,636
+9.2%
97,182
-0.4%
0.07%
+4.4%
Q1 2023$8,977,176
+101314.1%
97,5780.0%0.07%
-1.4%
Q4 2022$8,852
-99.9%
97,578
-0.5%
0.07%
+11.3%
Q3 2022$7,457,000
-12.3%
98,100
-2.5%
0.06%
-4.6%
Q2 2022$8,505,000
-6.0%
100,614
-2.4%
0.06%
+14.0%
Q1 2022$9,044,000
+0.2%
103,064
-0.1%
0.06%
+3.6%
Q4 2021$9,024,000
+1.9%
103,164
-4.8%
0.06%
-3.5%
Q3 2021$8,859,000
-10.6%
108,323
-0.3%
0.06%
-35.2%
Q2 2021$9,911,000
+4.7%
108,623
-1.9%
0.09%
-3.3%
Q1 2021$9,466,000
-12.4%
110,743
-3.2%
0.09%
-20.2%
Q4 2020$10,807,000
+7.8%
114,443
-0.8%
0.11%
+6.5%
Q3 2020$10,028,000
-20.3%
115,313
-19.9%
0.11%
-24.6%
Q2 2020$12,577,000
-82.0%
144,006
-83.0%
0.14%
-85.0%
Q1 2020$70,030,000
-3.4%
849,361
+11.0%
0.95%
+22.8%
Q4 2019$72,480,000
-20.3%
765,440
-26.9%
0.77%
-23.3%
Q3 2019$90,979,000
-29.7%
1,046,938
-26.2%
1.01%
-30.1%
Q2 2019$129,452,000
-14.4%
1,417,715
-9.9%
1.44%
-15.1%
Q1 2019$151,214,000
-9.4%
1,572,851
-19.2%
1.70%
-16.8%
Q4 2018$166,971,000
-4.1%
1,945,819
-3.7%
2.04%
+19.1%
Q3 2018$174,059,000
+14.7%
2,020,185
+0.6%
1.72%
+11.8%
Q2 2018$151,737,000
+5.5%
2,008,695
+12.9%
1.53%
+3.0%
Q1 2018$143,884,000
-2.9%
1,779,647
+0.9%
1.49%
+1.4%
Q4 2017$148,156,000
+3.3%
1,764,607
+5.6%
1.47%
-33.8%
Q3 2017$143,423,000
+3.1%
1,670,619
+0.3%
2.22%
+1.3%
Q2 2017$139,047,000
+12.2%
1,665,837
+0.1%
2.19%
+10.3%
Q1 2017$123,921,000
+4.3%
1,664,465
+2.1%
1.99%
+0.1%
Q4 2016$118,776,000
+4.3%
1,630,647
+13.0%
1.98%
-2.6%
Q3 2016$113,927,000
-3.8%
1,442,850
+0.5%
2.04%
-7.8%
Q2 2016$118,459,000
+17.4%
1,435,697
+3.0%
2.21%
+12.9%
Q1 2016$100,945,000
-6.7%
1,393,504
+10.8%
1.96%
-10.2%
Q4 2015$108,222,000
+11.1%
1,257,808
+18.7%
2.18%
+7.8%
Q3 2015$97,411,000
-5.0%
1,059,737
+1.6%
2.02%
+5.3%
Q2 2015$102,562,000
+6.9%
1,042,940
+7.2%
1.92%
+0.6%
Q1 2015$95,928,000
+9.5%
972,802
+2.9%
1.91%
+8.2%
Q4 2014$87,597,000
+141.1%
945,352
+145.0%
1.77%
+133.6%
Q3 2014$36,327,000
+1.4%
385,914
-2.5%
0.76%
+8.8%
Q2 2014$35,816,000
+4.2%
395,620
-2.1%
0.70%
-6.2%
Q1 2014$34,369,000
-1.1%
404,245
-6.5%
0.74%
-5.5%
Q4 2013$34,750,000
+0.8%
432,321
-3.8%
0.78%
-5.3%
Q3 2013$34,484,000
+9.6%
449,527
+1.1%
0.83%
+14.5%
Q2 2013$31,455,000444,8540.72%
Other shareholders
NOVARTIS A G shareholders Q3 2020
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders